TY - JOUR
T1 - Anesthesia and myotonic dystrophy type 2
T2 - A case series
AU - Weingarten, Toby N.
AU - Hofer, Ryan E.
AU - Milone, Margherita
AU - Sprung, Juraj
N1 - Funding Information:
Financial support This work was entirely supported by the Department of Anesthesiology, Mayo Clinic, Rochester, MN. The authors have no commercial or non-commercial affiliations or other associations that present or could be construed to present a conflict of interest.
PY - 2010/3
Y1 - 2010/3
N2 - Background: Myotonic dystrophy type 2 (DM2) is a genetically distinct disorder that shares some phenotypical features of myotonic dystrophy type 1 (DM1). However, anesthetic management of patients with DM2 has not been described. The purpose of this study is to report the anesthetic management of a series of patients with DM2 and to describe their response to anesthesia. Methods: We performed a computerized search of the Mayo Clinic medical records database looking for patients with DM2 who underwent general anesthesia. The medical records were reviewed for anesthetic technique, medications used, and postoperative complications. Results: We identified 19 patients with DM2 who underwent 39 general anesthetics, 17 monitored anesthetic care cases, and two regional anesthetics. The patients exhibited normal responses to succinylcholine, nondepolarizing neuromuscular blockers, neostigmine, induction agents, and volatile anesthetics. Serious postoperative complications related to DM2 did not occur. Conclusion: In our series, patients with DM2 tolerated commonly used anesthetics without obvious complications, and they exhibited normal responses to muscle relaxants. These observations suggest that these medications may be used safely in patients with DM2.
AB - Background: Myotonic dystrophy type 2 (DM2) is a genetically distinct disorder that shares some phenotypical features of myotonic dystrophy type 1 (DM1). However, anesthetic management of patients with DM2 has not been described. The purpose of this study is to report the anesthetic management of a series of patients with DM2 and to describe their response to anesthesia. Methods: We performed a computerized search of the Mayo Clinic medical records database looking for patients with DM2 who underwent general anesthesia. The medical records were reviewed for anesthetic technique, medications used, and postoperative complications. Results: We identified 19 patients with DM2 who underwent 39 general anesthetics, 17 monitored anesthetic care cases, and two regional anesthetics. The patients exhibited normal responses to succinylcholine, nondepolarizing neuromuscular blockers, neostigmine, induction agents, and volatile anesthetics. Serious postoperative complications related to DM2 did not occur. Conclusion: In our series, patients with DM2 tolerated commonly used anesthetics without obvious complications, and they exhibited normal responses to muscle relaxants. These observations suggest that these medications may be used safely in patients with DM2.
UR - http://www.scopus.com/inward/record.url?scp=77953287487&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77953287487&partnerID=8YFLogxK
U2 - 10.1007/s12630-009-9244-1
DO - 10.1007/s12630-009-9244-1
M3 - Article
C2 - 20077169
AN - SCOPUS:77953287487
SN - 0832-610X
VL - 57
SP - 248
EP - 255
JO - Canadian Journal of Anesthesia
JF - Canadian Journal of Anesthesia
IS - 3
ER -